If you have a commissioner who is that conflicted, recusal is a tricky business," said Susan F. Wood, who resigned as the director of the F. D. A. ’s Office of Women’s Health in 2005 in protest over the agency ’s decision to delay    approval of the   pill. Dr. Gottlieb’s nomination comes at a momentous time for the agency, which Mr. Trump has promised to significantly remake. The next commissioner will be charged with putting into practice a   law, passed in December, aimed at bringing drugs to market more quickly. 